Vaccine revenue for statutory health insurance Germany 2020

The graph shows vaccine revenue for statutory health insurance in Germany from 2006 to 2020. Most recently, influenza vaccine revenue through statutory health insurance in Germany amounted to 240 million euros. This was an increase compared to the previous year at 173 million euros.

Vaccine revenue for statutory health insurance in Germany from 2006 to 2020, by selected illness (in million euros)

Characteristic	Tick-borne encephalitis	Meningococcal meningitis	Measels	Influenza	Pneumococcus	Human papilloma virus (HPV)	Rotavirus	Whooping cough (pertussis)
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

June 2021

More information

Region

Germany

Survey time period

2006 to 2020

Supplementary notes

In 2007, vaccinations were included in the mandatory services catalog for statutory health insurance.
The figures are based on vaccine acquisition by public pharmacies.
Measles: including combination vaccines with mumps, German measles, chicken pox.
Whooping cough: including combination vaccines with diphtheria, tetanus etc.

Citation formats